Accelmed Partners II L.P. 13D and 13G filings for NeuroPace, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-23 5:11 pm Purchase | 2022-11-21 | 13D | NeuroPace, Inc. NPCE | Accelmed Partners II L.P. | 4,432,948 17.800% | 390,291 (+9.65%) | Filing |
| 2022-11-21 07:00 am Purchase | 2022-11-18 | 13D | NeuroPace, Inc. NPCE | Accelmed Partners II L.P. | 4,042,657 16.200% | 4,042,657 (New Position) | Filing |